中文名稱(chēng):YM-201636 | 英文名稱(chēng):YM-201636 |
CAS:371942-69-7 | 有效期: 一年 |
YM201636 is a selective PIKfyve inhibitor with IC50 of 33 nM, less potent to p110α.
IC50 value: 33 nM [1]
Target: PIKfyve
in vitro: YM201636 potently inhibits mammalian PIKfyve with an IC50 of 33 nM but not yeast orthologue Fab1 with an IC50 of >5 μM, exhibiting around 100-fold selectivity for PtdIns3P p110α with an IC50 of 3 μM. YM201636 (0.8 μM) significantly decreases the production of PtdIns(3,5)P2 by 80% in serum-starved NIH3T3 cells followed by serum stimulation with no effect on serum-stimulated protein kinase B (PKB) Ser 473 phosphorylation. YM-201636 reversibly impairs endosomal trafficking in NIH3T3 cells by blocking PIKfyve and PtdIns(3,5)P2 production, mimicking the effect produced by depleting PIKfyve with siRNA. YM-201636 (0.8 μM) also significantly reduces retroviruses budding from cells by 80%, apparently through interfering with the endosomal sorting complex required for transport (ESCRT) machinery [1]. In 3T3L1 adipocytes, YM-201636 inhibits basal and insulin-activated 2-deoxyglucose uptake with an IC50 of 54 nM, with almost complete inhibition at doses as low as 160 nM. YM-201636 (0.1 μM) has also been shown to completely block insulin-dependent activation of class IA PI 3-kinase [2]. Although not involved in NPM-ALK-dependent proliferation and migration, YM201636 (0.4 μM) strongly reduces invasive capacities of NPM-ALK-expressing cells and their capacity to degrade the extracellular matrix [3].
in vivo:
[1]. Jefferies HB, et al. A selective PIKfyve inhibitor blocks PtdIns(3,5)P(2) production and disrupts endomembrane transport and retroviral budding. EMBO Rep, 2008, 9(2), 164-170.
[2]. Ikonomov OC, et al. YM201636, an inhibitor of retroviral budding and PIKfyve-catalyzed PtdIns(3,5)P2 synthesis, halts glucose entry by insulin in adipocytes. Biochem Biophys Res Commun, 2009, 382(3), 566-570.
[3]. Dupuis-Coronas S, et al. The nucleophosmin-anaplastic lymphoma kinase oncogene interacts, activates, and uses the kinase PIKfyve to increase invasiveness.J Biol Chem, 2011, 286(37), 32105-32114.
成立日期 | 2015-05-08 (10年) | 注冊(cè)資本 | 10萬(wàn)元人民幣 |
員工人數(shù) | 1-10人 | 年?duì)I業(yè)額 | ¥ 100萬(wàn)以?xún)?nèi) |
主營(yíng)行業(yè) | 化學(xué)試劑,通用試劑,格氏試劑,綠色化學(xué)產(chǎn)品,基礎(chǔ)有機(jī)試劑 | 經(jīng)營(yíng)模式 | 貿(mào)易,試劑,服務(wù) |
產(chǎn)品名稱(chēng) | 價(jià)格 | 公司名稱(chēng) | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢(xún)價(jià) |
VIP6年
|
上海澤葉生物科技有限公司
|
2024-12-23 | |
詢(xún)價(jià) |
VIP3年
|
河南威梯希化工科技有限公司
|
2024-12-23 | |
¥438 |
VIP3年
|
TargetMol中國(guó)(陶術(shù)生物)
|
2024-12-12 | |
¥9269.90 |
VIP1年
|
上海阿拉丁生化科技股份有限公司
|
2024-11-29 | |
詢(xún)價(jià) |
南京百鑫德諾生物科技有限公司
|
2024-09-26 |